Market Place
Sourcing Support
Lenvatinib Mesilate: Drug Interactions and Important Consideratio
29 May 2025 //
PRESS RELEASE
The Difference Between Dabigatran Etexilate Mesylate and Pradaxa
18 Mar 2025 //
PRESS RELEASE
The Impact of Sugammadex Sodium on the Autonomic Nervous System
17 Aug 2024 //
PRESS RELEASE
Synthesis Methods of Lenvatinib Mesylate API
07 Aug 2024 //
PRESS RELEASE
Sourcing Strategies for High-Quality Gadobutrol API
24 Jul 2024 //
PRESS RELEASE
Quality Control in Parecoxib Sodium API Production
16 Jul 2024 //
PRESS RELEASE
Ixazomib Citrate API: A Weapon for Multiple Myeloma Treatment
15 Jul 2024 //
PRESS RELEASE
Mechanism of Action of Silodosin API & Its Role Prostate Health
10 Jul 2024 //
PRESS RELEASE
Dacomitinib: A Targeted Therapy for Non-Small Cell Lung Cancer
08 Jul 2024 //
PRESS RELEASE
Comparative Analysis of Abemaciclib & Other CDK4/6 Inhibitors
08 Jul 2024 //
PRESS RELEASE
Qingmu’s Quality Control of Nilotinib API
01 Jul 2024 //
PRESS RELEASE
Brivaracetam API: A Key Component in Epilepsy Treatment
01 Jul 2024 //
PRESS RELEASE
Brexpiprazole API in a Versatile Antipsychotic Medication
24 Jun 2024 //
PRESS RELEASE
Guide to Common Veterinary APIs
24 Jun 2024 //
PRESS RELEASE
Ensuring Quality in Bisoprolol Fumarate API Supplies
18 Jun 2024 //
PRESS RELEASE
Axitinib: A Targeted Therapy for Advanced Renal Cell Carcinoma
17 Jun 2024 //
PRESS RELEASE
Are Generic Ruxolitinib Therapeutically Equivalent to Brand Ruxol
12 Jun 2024 //
PRESS RELEASE
Impact of Organic Impurities on the Stability of API
12 Jun 2024 //
PRESS RELEASE
Ponatinib HCL: A Targeted Therapy for CML and Ph+ ALL
11 Jun 2024 //
PRESS RELEASE
Ixazomib Citrate API in the Age of Biosimilars
04 Jun 2024 //
PRESS RELEASE
Bisoprolol Fumarate: A Vital API in Cardiovascular Care
03 Jun 2024 //
PRESS RELEASE
Comparing the Cost of Rotigotine API from Different Regions
30 May 2024 //
PRESS RELEASE
Similarities &Differences Ruxolitinib Phosphate & Ruxolitinib API
28 May 2024 //
PRESS RELEASE
Manufacturing Processes of Apalutamide API
15 May 2024 //
PRESS RELEASE
Highlighting Bisoprolol API for Atrial Fibrillation Treatment
15 May 2024 //
PRESS RELEASE
Mitigating Risks in the Oclacitinib Maleate API Supply Chain
15 May 2024 //
PRESS RELEASE
Dabigatran Etexilate for Pulmonary Embolism
08 May 2024 //
PRESS RELEASE
Mitigating Shortages Strategies for Rotigotine Stable Supply
08 May 2024 //
PRESS RELEASE
Nilotinib HCL A Targeted Therapy for Chronic Myelogenous Leukemia
29 Apr 2024 //
PRESS RELEASE
Ponatinib Hydrochloride Balancing Efficacy & Safety in Leukemia
29 Apr 2024 //
PRESS RELEASE
Dabigatran Etexilate: Redefining Anticoagulant Therapy
16 Apr 2024 //
RESS RELEASE
A Comparison Between Maropitant Citrate and Maropitant
15 Apr 2024 //
PRESS RELEASE
Understanding the Chemical Properties of Rotigotine API
03 Apr 2024 //
PRESS RELEASE
Ruxolitinib and its Phosphate Form New Treatment Option
26 Mar 2024 //
PRESS RELEASE
Pharmaceutical Compositions and Process of Ponatinib HCl API
13 Mar 2024 //
PRESS RELEASE
Nilotinib Hydrochloride for Pediatric CML for Younger Patients
19 Feb 2024 //
PRESS RELEASE
Oclacitinib for Treating Pruritus and Beyond
30 Jan 2024 //
PRESS RELEASE
The Uses of Rotigotine in Parkinson’s Disease Treatment
24 Jan 2024 //
PRESS RELEASE
Potential of Lenvatinib Mesylate in Liver Cancer Treatment
15 Jan 2024 //
PRESS RELEASE
Unlocking the Power of Human APIs in Healthcare
11 Dec 2023 //
PRESS RELEASE
A Detailed Exploration of Dabigatran Pellets and Dabigatran Caps
06 Dec 2023 //
PRESS RELEASE
Brexpiprazole: A New Frontier in Mental Health Treatment
10 Nov 2023 //
PRESS RELEASE
The Application of Ruxolitinib in COVID-19
08 Oct 2023 //
PRESS RELEASE
Qingmu passed cGMP site inspection from USFDA
29 Jun 2023 //
PRESS RELEASE
